YAG Laser Versus Punch Biopsy for the Treatment of Tattoo Skin Markers

This study has been completed.

Sponsored by:	Bispebjerg Hospital
Information provided by:	Bispebjerg Hospital
ClinicalTrials.gov Identifier:	NCT00271674

Purpose

The purpose of the study is to compare patient satisfaction, clinical efficacy and adverse effects of Q-switched YAG laser versus punch biopsies for the treatment of tattoo dots that are applied as skin markers in relation to X-ray treatment of malignant disorders.

Condition	Intervention
Tattoo Skin Markers	Device: Q-switched YAG laser

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Active Control, Single Group Assignment

Further study details as provided by Bispebjerg Hospital:

Study Start Date:	January 2006
Study Completion Date:	December 2007

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

18 years or older,
Skin types I-IV,
No previous laser treatment for the condition.

Exclusion Criteria:

Younger than 18 years,
Skin types V-VI,
Pregnant or lactating women,
Previous laser treatment for the condition,
Recent exposure to sun or sun-beds,
Treatment with oral retinoids within 3 months,
Tendency to produce hypertrophic scars or keloids,
Immunosuppressive treatment or disorders

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00271674

Locations

Denmark, Copenhagen NV
Bispebjerg Hospital
Copenhagen, Copenhagen NV, Denmark, 2400

Sponsors and Collaborators

Bispebjerg Hospital

Investigators

Principal Investigator:

Merete Haedersdal, MD, PhD, DrMedSci.

Bispebjerg Hospital

More Information

Study ID Numbers:	KF-01-275533
Study First Received:	January 3, 2006
Last Updated:	June 2, 2008
ClinicalTrials.gov Identifier:	NCT00271674
Health Authority:	Denmark: The Ministry of the Interior and Health

ClinicalTrials.gov processed this record on January 16, 2009